Related Experiment Video

Updated: Mar 18, 2026

Studying Chronic Exposure of Mice to Ultraviolet B Radiation
03:20

Studying Chronic Exposure of Mice to Ultraviolet B Radiation

Published on: August 19, 2025

2.2K

[Urticaria pigmentosa: clinical and therapeutic aspects for the paediatrician]

Catherina Moll-Manzur1, Esteban Araos-Baeriswyl2, Camila Downey3

  • 1Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile. catherina.moll@gmail.com.

Archivos Argentinos De Pediatria
|July 12, 2016
PubMed

Insights

Urticaria pigmentosa, a common pediatric skin condition, presents as yellow-brown spots. This article updates pediatricians on diagnosing and treating this form of mastocytosis.

Area of Science:

  • Pediatric Dermatology
  • Mast Cell Disorders
  • Clinical Pediatrics

Background:

  • Urticaria pigmentosa (UP) is the most frequent presentation of mastocytosis in children.
  • It is characterized by distinctive yellow-to-brown macules or papules, predominantly on the trunk and extremities.
  • Understanding UP is crucial for pediatricians due to its diagnostic and therapeutic considerations.

Purpose of the Study:

  • To provide an updated overview of urticaria pigmentosa for pediatricians.
  • To highlight key diagnostic criteria and considerations for pediatric mastocytosis.
  • To discuss current therapeutic strategies and implications for managing UP.

Main Methods:

  • Review of current literature on pediatric urticaria pigmentosa.
  • Synthesis of diagnostic guidelines and clinical presentation data.
  • Analysis of therapeutic options and management protocols.

Main Results:

  • Urticaria pigmentosa is the most common pediatric mastocytosis, presenting with characteristic skin lesions.
  • Accurate diagnosis relies on clinical presentation and can be supported by biopsy and genetic testing.
  • Management focuses on symptomatic relief and monitoring for systemic involvement.

Conclusions:

  • Urticaria pigmentosa requires informed pediatric management.
  • Early diagnosis and appropriate treatment are essential for optimal outcomes.
  • This review serves as a practical guide for pediatricians managing this condition.

Keywords:
ChildCutaneousMastocytosisPigmentation disordersUrticaria pigmentosa

More Related Videos

Basophil Activation Test for Allergy Diagnosis07:22

Basophil Activation Test for Allergy Diagnosis

Published on: May 31, 2021

9.8K
Antigenic Liposomes for Generation of Disease-specific Antibodies10:31

Antigenic Liposomes for Generation of Disease-specific Antibodies

Published on: October 25, 2018

12.9K

Related Concept Videos

Changes in Skin Color: Clinical Perspectives01:14

Changes in Skin Color: Clinical Perspectives

The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
4.1K
Drug Toxicity: Allergic Reactions01:30

Drug Toxicity: Allergic Reactions

Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial...
104
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
645
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
360
Hypersensitivities01:30

Hypersensitivities

Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
8.1K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
313